Johnson & Johnson logo
Johnson & Johnson (JNJ)
Compare

Johnson & Johnson (JNJ) Price/FCF Ratio: 32.75

popular:market cap|pe ratio|revenue|price history|total return

Is Johnson & Johnson’s Price/FCF ratio high or low?

Johnson & Johnson's Price/FCF ratio of 32.75 is 40% above its 5-year average of 23.44, near the high end of its 5-year range (17.69–32.75).

The Price/FCF ratio for Johnson & Johnson (JNJ) is 32.75. It is above its 12-month average by 21.12% (27.04).

P/E Ratio|FCF Growth|Operating Margin|All Metrics

JNJ Price/FCF Ratio Chart

JNJ Price/FCF Ratio
32.75+60.38% 1Y
Zoom

JNJ Average Price/FCF Ratio Chart

JNJ Current vs Average Price/FCF Ratio Chart

JNJ Price/FCF Ratio Metrics

PRICE/FCF RATIO

32.75

PRICE/FCF RATIO AVG TTM

27.04

PRICE/FCF RATIO AVG 3Y

23.86

PRICE/FCF RATIO AVG 5Y

23.44

PRICE/FCF RATIO AVG 10Y

22.15

PRICE/FCF RATIO AVG 15Y

20.87

PRICE/FCF RATIO AVG 20Y

19.31

CURRENT VS TTM AVG

+21.12%

CURRENT VS 3Y AVG

+37.26%

CURRENT VS 5Y AVG

+39.70%

CURRENT VS 10Y AVG

+47.87%

CURRENT VS 15Y AVG

+56.91%

CURRENT VS 20Y AVG

+69.58%

JNJ Competitors' Price/FCF Ratio

NAMEMARKET CAPPRICE/FCF RATIOTTM3Y5Y
Johnson & Johnson (JNJ)—32.7527.0423.8623.44
Pfizer Inc. (PFE)$146.36B15.5013.8919.4416.06
Merck & Co., Inc. (MRK)$293.02B20.7518.1321.0221.60
AbbVie Inc. (ABBV)$399.54B19.2120.2817.0014.78
Eli Lilly and Company (LLY)$1.07T75.2193.94339.16163.16
Bristol-Myers Squibb Company (BMY)$114.14B9.597.748.439.56

Free Cash Flow Valuation

P/FCF Ratio

32.8

FCF Yield

3.05%

Johnson & Johnson Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Johnson & Johnson Price/FCF Ratio FAQ

What is the Price/FCF ratio for Johnson & Johnson (JNJ)?
The Price/FCF ratio for JNJ stock is 32.75.
Is Johnson & Johnson's Price/FCF ratio high or low?
Johnson & Johnson's Price/FCF ratio of 32.75 is 40% above its 5-year average of 23.44, near the high end of its 5-year range (17.69–32.75).
What is the TTM average Price/FCF ratio for Johnson & Johnson (JNJ)?
The TTM average Price/FCF ratio for JNJ stock is 27.04.
What is the 3Y average Price/FCF ratio for Johnson & Johnson (JNJ)?
The 3Y average Price/FCF ratio for JNJ stock is 23.86.
What is the 5Y average Price/FCF ratio for Johnson & Johnson (JNJ)?
The 5Y average Price/FCF ratio for JNJ stock is 23.44.
What is the 10Y average Price/FCF ratio for Johnson & Johnson (JNJ)?
The 10Y average Price/FCF ratio for JNJ stock is 22.15.
What is the 15Y average Price/FCF ratio for Johnson & Johnson (JNJ)?
The 15Y average Price/FCF ratio for JNJ stock is 20.87.
What is the 20Y average Price/FCF ratio for Johnson & Johnson (JNJ)?
The 20Y average Price/FCF ratio for JNJ stock is 19.31.

Johnson & Johnson Price/FCF Ratio History

DATEPRICE/FCF RATIO
2026-06-1032.75
2026-06-0932.56
2026-06-0831.90
2026-06-0531.98
2026-06-0431.35
2026-06-0330.67
2026-06-0230.62
2026-06-0130.71
2026-05-2930.96
2026-05-2831.71
2026-05-2731.78
2026-05-2631.62
2026-05-2232.20
2026-05-2131.84
2026-05-2031.51
2026-05-1931.60
2026-05-1831.45
2026-05-1531.15
2026-05-1431.71
2026-05-1331.66
2026-05-1230.81
2026-05-1130.42
2026-05-0830.41
2026-05-0730.57
2026-05-0630.86
2026-05-0530.99
2026-05-0430.80
2026-05-0131.21
2026-04-3031.58
2026-04-2931.23
2026-04-2831.30
2026-04-2730.96
2026-04-2431.26
2026-04-2331.69
2026-04-2231.06
2026-04-2128.00
2026-04-2028.56
2026-04-1729.00
2026-04-1629.04
2026-04-1529.55
2026-04-1429.73
2026-04-1329.46
2026-04-1029.53
2026-04-0929.88
2026-04-0829.88
2026-04-0729.52
2026-04-0629.84
2026-04-0230.09
2026-04-0130.23
2026-03-3130.27
2026-03-3030.03
2026-03-2729.77
2026-03-2629.63
2026-03-2529.71
2026-03-2429.13
2026-03-2329.15
2026-03-2029.14
2026-03-1929.42
2026-03-1829.38
2026-03-1729.48
2026-03-1630.11
2026-03-1329.90
2026-03-1229.97
2026-03-1130.09
2026-03-1030.18
2026-03-0930.04
2026-03-0629.77
2026-03-0529.67
2026-03-0430.37
2026-03-0330.55
2026-03-0230.78
2026-02-2730.76
2026-02-2630.15
2026-02-2530.36
2026-02-2430.49
2026-02-2330.44
2026-02-2030.03
2026-02-1930.57
2026-02-1830.33
2026-02-1730.13
2026-02-1330.14
2026-02-1230.28
2026-02-1129.82
2026-02-1030.36
2026-02-0930.40
2026-02-0630.57
2026-02-0530.29
2026-02-0429.87
2026-02-0329.70
2026-02-0229.40
2026-01-3028.95
2026-01-2928.95
2026-01-2829.01
2026-01-2728.59
2026-01-2628.22
2026-01-2328.04
2026-01-2227.83
2026-01-2127.77
2026-01-2027.80
2026-01-1627.86
2026-01-1527.97
2026-01-1427.84
2026-01-1327.22
2026-01-1226.72
2026-01-0926.04
2026-01-0826.21
2026-01-0726.43
2026-01-0626.09
2026-01-0526.03
2026-01-0226.41
2025-12-3126.36
2025-12-3026.36
2025-12-2926.44
2025-12-2626.45
2025-12-2426.47
2025-12-2326.21
2025-12-2226.41
2025-12-1926.29
2025-12-1826.54
2025-12-1726.79
2025-12-1626.66
2025-12-1527.28
2025-12-1226.95
2025-12-1126.75
2025-12-1026.31
2025-12-0925.47
2025-12-0825.68
2025-12-0525.72
2025-12-0425.79
2025-12-0326.16
2025-12-0226.17
2025-12-0126.16
2025-11-2826.36
2025-11-2626.44
2025-11-2526.33
2025-11-2426.25
2025-11-2125.98
2025-11-2025.87
2025-11-1925.80
2025-11-1825.48
2025-11-1725.42
2025-11-1424.96
2025-11-1324.87
2025-11-1224.76
2025-11-1124.69
2025-11-1024.00
2025-11-0723.77
2025-11-0623.82
2025-11-0523.69
2025-11-0423.80
2025-11-0323.73
2025-10-3124.06
2025-10-3024.08
2025-10-2923.77
2025-10-2823.81
2025-10-2724.24
2025-10-2424.26
2025-10-2324.52
2025-10-2224.58
2025-10-2128.31
2025-10-2028.58
2025-10-1728.51
2025-10-1628.34
2025-10-1528.20
2025-10-1428.16
2025-10-1328.16
2025-10-1028.14
2025-10-0928.19
2025-10-0827.99
2025-10-0727.87
2025-10-0627.76
2025-10-0327.83
2025-10-0227.44
2025-10-0127.45
2025-09-3027.36
2025-09-2926.79
2025-09-2626.51
2025-09-2526.22
2025-09-2426.07
2025-09-2326.05
2025-09-2225.70
2025-09-1925.99
2025-09-1825.69
2025-09-1726.14
2025-09-1626.03
2025-09-1526.17
2025-09-1226.27
2025-09-1126.33
2025-09-1025.93
2025-09-0926.11
2025-09-0826.28
2025-09-0526.32
2025-09-0426.37
2025-09-0326.26
2025-09-0226.27
2025-08-2926.14
2025-08-2825.88
2025-08-2726.08
2025-08-2626.04
2025-08-2526.32
2025-08-2226.45
2025-08-2126.40
2025-08-2026.38
2025-08-1926.23
2025-08-1826.00
2025-08-1526.06
2025-08-1425.78
2025-08-1325.73
2025-08-1225.49
2025-08-1125.64
2025-08-0825.57
2025-08-0725.31
2025-08-0625.17
2025-08-0525.19
2025-08-0425.23
2025-08-0124.69
2025-07-3124.30
2025-07-3024.68
2025-07-2924.80
2025-07-2824.52
2025-07-2524.83
2025-07-2425.02
2025-07-2322.07
2025-07-2221.91
2025-07-2121.45
2025-07-1821.36
2025-07-1721.27
2025-07-1621.50
2025-07-1520.25
2025-07-1420.46
2025-07-1120.47
2025-07-1020.58
2025-07-0920.39
2025-07-0820.33
2025-07-0720.26
2025-07-0320.36
2025-07-0220.30
2025-07-0120.35
2025-06-3019.93
2025-06-2719.89
2025-06-2619.84
2025-06-2519.87
2025-06-2419.86
2025-06-2319.75
2025-06-2019.55
2025-06-1819.67
2025-06-1719.88
2025-06-1620.26
2025-06-1320.50
2025-06-1220.44
2025-06-1120.26
2025-06-1020.42
2025-06-0920.26
2025-06-0620.23
2025-06-0520.05
2025-06-0419.99
2025-06-0320.15
2025-06-0220.28
2025-05-3020.25
2025-05-2920.04

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

P/E RatioFCF GrowthOperating MarginAll Metrics

About Johnson & Johnson

Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.

New Brunswick, NJ
138,100 employees
www.jnj.com
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
View full financials